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Based on the epidemiological findings and clinical characteristics, hantaviruses (HTNV) (Bunyaviridae family) can cause hemorrhagic fever with renal syndrome (HFRS) or hantavirus cardiopulmonary syndrome (HCPS) (respectively hantavirus pulmonary syndrome \[HPS\]).\[[@ref1][@ref2]\] HCPS was first recognized in 1993 in the Four Corners region of the southwestern United States.\[[@ref3]\] Based on the available data, HCPS-causing viruses show a rapid disease course with serious pulmonary symptoms\[[@ref1][@ref4][@ref5][@ref6][@ref7][@ref8]\] with a 40% case-fatality rate (CFR).\[[@ref1][@ref2]\] There is growing evidence that HFRS and HCPS partly overlap.\[[@ref6][@ref9]\] In patients with HFRS, respiratory symptoms are frequent and are linked to Puumala virus (PUUV) infection.\[[@ref2][@ref6][@ref10]\] In areas where both PUUV and Dobrava virus (DOBV) circulate, more than half of HFRS patients present with abnormal pulmonary X-ray findings and transient EKG changes, mostly in the oliguric phase.\[[@ref11]\] In Kosovo, each year, we treat several sporadic cases of HFRS, and every fourth or 5^th^ year, epidemic features present with different clinical forms of the HTNV disease.\[[@ref12]\] Over 30 years, we have evidenced only one confirmed case that developed severe HCPS. Here, we report a case of a 20 yearold male with HFRS and HCPS caused by Dobrava-Belgrade hantavirus, successfully treated in the Department of Infectious Diseases.

C[ASE]{.smallcaps} R[EPORT]{.smallcaps} {#sec1-2}
=======================================

At the end of April 2014, a previously healthy 20 yearold male living in a rural area (near Ferizaj, Kosovo) developed a febrile illness for 8 days before admission (the patient consent form has been obtained) Two days before hospitalization (day 6 postsymptom onset \[PSO\]), he developed diarrhea with dark stools, dark urine, conjunctival injection (cherry eyes), and severe malaise \[[Figure 1a](#F1){ref-type="fig"}\]. Laboratory tests on admission day (day 8 PSO) showed anemia with thrombocytopenia, elevated blood urea nitrogen (BUN) and creatinine, high C-reactive protein, high procalcitonin, elevated aspartate aminotransferase, alanine aminotransferase, and creatine kinase (CK). Initial chest X-ray was unremarkable. On hospital day 2 (day 9 PSO), BUN and creatinine increased rapidly, and the patient became anuric, with hypertension and bradycardia. Renal replacement therapy was initiated and continued until day 52 PSO. On hospital day 4 (day 11 PSO), the disease was complicated with agitation and high fever, and the patient became tachy dyspneic and developed acute severe respiratory distress. Chest X-ray showed extensive bilateral infiltrates and enlarged heart shadow with rapid improvement by day 15 PSO \[[Figure 1d](#F1){ref-type="fig"}--[f](#F1){ref-type="fig"}\]. EKG (day 11 PSO) showed sinus rhythm 114 b/min, with 2 mm ST depression on lead II, III, and aVF suggesting acute coronaritis \[[Figure 1b](#F1){ref-type="fig"} and [c](#F1){ref-type="fig"}\]. Abdominal ultrasound presented enlarged liver (182 mm), acute renal inflammation, and abdominal-free liquid \[[Figure 1g](#F1){ref-type="fig"}--[i](#F1){ref-type="fig"}\]. In addition, laboratory tests presented acute kidney injury and acute lung injury \[[Table 1](#T1){ref-type="table"}\]. The patient was intubated and mechanically ventilated; intravenous ampicillin, ribavirin, and crystalloid infusions were commenced immediately on arrival to the Intensive Care Unit. The critical respiratory phase lasted 7 days, contrary to the renal phase that lasted 15 days, after which urine output increased entering polyuric phase. Ventilation support was weaned off after 11 days. On day 25 PSO, the patient was transferred to the Infectious Disease department, and after 44 hospital days (day 52 PSO), the patient was discharged in good clinical condition; still with mild anemia, elevated BUN, and creatinine, but without the need for dialysis. After a 2-year follow-up, the patient still had mild anemia and findings of CK disease.

![Clinical and radiological findings in the reported case: (a) Cherry eyes; (b and c) electrocardiogram (present 2 mm ST depression in D~2~, D~3~, and a VF on day of hospitalization in Intensive Care Unit \[POS 11\]). (d) Radiography on hospitalization (POS 8) (normal chest). (e) Radiography (POS 11) (bilateral lung damage). (f) Radiography (POS 17) (four days after intubation present complete lung resolution). (g-i) Ultrasonography presenting enlarged liver (182 mm), enlarged spleen, acute renal inflammation, and abdominal-free liquid](JGID-10-22-g001){#F1}

###### 

Laboratory findings in the patient with hemorrhagic fever with renal syndrome and hantavirus cardiopulmonary syndrome in the Intensive Care Unit

![](JGID-10-22-g002)

Initial diagnosis of HFRS was made on the day of hospitalization by rapid antihantavirus test (immunochromatography SD, INCCE (IgG and IgM positive for entire Hantan viruses group, Standard Diagnostics, Republic of Korea).

Next day, serum sample has been tested for the presence of antibodies against Hantavirus Dobrava/Hantaan IgG/IgM, with ELISA following the manufacturer\'s instructions (Progene, Germany), at the National Institute of Public Health of Kosovo, Prishtina. Specific IgM and IgG antibodies against Dobrava/Hantaan virus were detected. The Line Hanta plus IgG, IgM *in vitro* test for detection of IgM, and/or IgG antibodies against the Hantavirus serotypes Puumala, Sin Nombre, Hantaan, Dobrava, and Seoul was used. Following manufacturer\'s instructions (Mikrogen Diagnostik, Germany), serotyping is possible using the recommended Line HantaPlus IgG test. Based on instructions for result interpretation from the producer, IgM antibodies were reactive on Dobrava, Hantaan, and Seoul HTNV, and IgG antibodies were more reactive on Dobrava compared to Hantaan and were negative to other hantavirus serotypes. RT-PCR from a blood sample was negative for HTNV, tested by commercial test (Primerdesign UK). Following information gained through serological tests, infection with Hantavirus Dobrava could be taken into consideration \[[Table 2](#T2){ref-type="table"}\].

###### 

Laboratory assays used in diagnosis
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Written informed consent from the patient who participated in this study was obtained.
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========================

The HTNV cause vascular leak by injuring the endothelial vascular cells resulting in capillary leak.\[[@ref1][@ref2]\] The form of clinical presentation depends directly on the localization of the process, causing tubulointerstitial damage in the renal system or pulmonary edema with perialveolar infiltration and pleural effusion.\[[@ref1][@ref2][@ref7][@ref13]\] The severe form of HFRS has a CFR of 5%--15%, whereas HCPS has a much higher CFR, 40%.\[[@ref1][@ref2][@ref7]\] Viral strain seems to be determinant key for the organ tropism and the diseases.\[[@ref7][@ref14]\] In patients with HFRS, respiratory symptoms appear more frequently and are especially linked to PUUV infection.\[[@ref9][@ref10]\] In areas where both PUUV and DOBV are circulating, half of HFRS patients present with abnormal pulmonary X-ray findings and transient EKG changes, mostly in the oliguric phase.\[[@ref11]\] Contrary to adult acute respiratory distress syndrome (ARDS) seen in systemic infections and systemic noninfectious diseases, respiratory failure in HCPS usually resolves within a few days and is followed by a polyuric phase, as our case demonstrates.\[[@ref1]\] With increasing contact between humans and the natural host for HTNV, the spreading of these viruses can be easier and can be responsible for the pulmonary syndrome in all endemic areas.\[[@ref14]\]

C[ONCLUSION]{.smallcaps} {#sec1-4}
========================

In endemic areas, hantavirus infection should be considered in the differential diagnosis of acute respiratory distress in previously healthy adults with acute renal failure, hemorrhagic syndrome, fever, leukopenia, thrombocytopenia, and a history of possible exposure. We wish to point out that the lung involvement during HFRS is frequent, and ARDS may also be encountered in Europe, which is usually caused by the PUUV of the Hantavirus genus but does not rule out Dobrava strain, as in our case.
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